Vinculin activators target integrins from within the cell to increase melanoma sensitivity to chemotherapy

Molecular Cancer Research

Volumn 9, Issue 6, 2011, Pages 712-723

  Nelson, Elke S ^a   Folkmann, Andrew W ^a   Henry, Michael D ^a   DeMali, Kris A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DNA; GREEN FLUORESCENT PROTEIN; INTEGRIN; MYC PROTEIN; PEPTIDE; PROTEIN P53; UNCLASSIFIED DRUG; VINCULIN ACTIVATING PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ADHESION; CHEMOSENSITIVITY; CHEMOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIAL PROTEINS; CELL ADHESION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FIBROBLASTS; HELA CELLS; HUMANS; INTEGRINS; MELANOMA; MICE; PEPTIDE FRAGMENTS; SKIN NEOPLASMS; VINCULIN;

EID: 79959206901     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0599     Document Type: Article

References (46)

1. Schoenwaelder SM, Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol 1999;11:274-86. (Pubitemid 29164045)
2. DeMali KA, Burridge K. Coupling membrane protrusion and cell adhesion. J Cell Sci 2003;116:2389-97. (Pubitemid 36790121)
3. Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 1998;50:197-263. (Pubitemid 28304026)
4. Moissoglu K, Schwartz MA. Integrin signalling in directed cell migration. Biol Cell 2006;98:547-55. (Pubitemid 44383371)
5. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001;13:555-62. (Pubitemid 32817013)
6. Montgomery AM, Reisfeld RA, Cheresh DA. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A 1994;91:8856-60. (Pubitemid 2148815)
7. Petitclerc E, Stromblad S, von Schalscha TL, Mitjans F, Piulats J, Montgomery AM, et al. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 1999;59:2724-30.
8. Dechantsreiter MA, Planker E, Matha B, Lohof E, Holzemann G, Jonczyk A, et al. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem 1999;42:3033-40.
9. Nisato RE, Tille JC, Jonczyk A, Goodman SL, Pepper MS. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. Angiogenesis 2003;6:105-19. (Pubitemid 38173862)
10. Maubant S, Saint-Dizier D, Boutillon M, Perron-Sierra F, Casara PJ, Hickman JA, et al. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrinmediated death in human endothelial cells. Blood 2006;108:3035-44.
11. Legler DF, Wiedle G, Ross FP, Imhof BA. Superactivation of integrin alphavbeta3 by low antagonist concentrations. J Cell Sci 2001;114:1545-53. (Pubitemid 32427840)
12. Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 2009;15:392-400.
13. Weis SM, Stupack DG, Cheresh DA. Agonizing integrin antagonists? Cancer Cell 2009;15:359-61.
14. Lewis JM, Truong TN, Schwartz MA. Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci U S A 2002;99:3627-32. (Pubitemid 34252157)
15. Truong T, Sun G, Doorly M, Wang JY, Schwartz MA. Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci U S A 2003;100:10281-6. (Pubitemid 37071869)
16. Schwartz MA, McRoberts K, Coyner M, Andarawewa KL, Frierson HF Jr, Sanders JM, et al. Integrin agonists as adjuvants in chemotherapy for melanoma. Clin Cancer Res 2008;14:6193-7.
17. Cantor JM, Ginsberg MH, Rose DM. Integrin-associated proteins as potential therapeutic targets. Immunol Rev 2008;223:236-51. (Pubitemid 351986185)
18. Burridge K, Mangeat P. An interaction between vinculin and talin. Nature 1984;308:744-6. (Pubitemid 14127674)
19. Horwitz A, Duggan K, Buck C, Beckerle MC, Burridge K. Interaction of plasma membrane fibronectin receptor with talin-a transmembrane linkage. Nature 1986;320:531-3. (Pubitemid 16045116)
20. Coll JL, Ben-Ze'ev Ze'ev A, Ezzell RM, Rodriguez Fernandez JL, Baribault H, Oshima RG, et al. Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion. Proc Natl Acad Sci U S A 1995;92:9161-5.
21. Volberg T, Geiger B, Kam Z, Pankov R, Simcha I, Sabanay H, et al. Focal adhesion formation by F9 embryonal carcinoma cells after vinculin gene disruption. J Cell Sci 1995;108:2253-60.
22. Xu W, Baribault H, Adamson ED. Vinculin knockout results in heart and brain defects during embryonic development. Development 1998;125:327-37.
23. Saunders RM, Holt MR, Jennings L, Sutton DH, Barsukov IL, Bobkov A, et al. Role of vinculin in regulating focal adhesion turnover. Eur J Cell Biol 2006;>85:487-500.
24. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 2007;179:1043-57. (Pubitemid 350223497)
25. Chen H, Cohen DM, Choudhury DM, Kioka N, Craig SW. Spatial distribution and functional significance of activated vinculin in living cells. J Cell Biol 2005;169:459-70. (Pubitemid 40686696)
26. Cohen DM, Kutscher B, Chen H, Murphy DB, Craig SW. A conformational switch in vinculin drives formation and dynamics of a talin-vinculin complex at focal adhesions. J Biol Chem 2006;281:16006-15. (Pubitemid 43848494)
27. Tran Van Nhieu G, Ben-Ze'ev Ze'ev A, Sansonetti PJ. Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J 1997;16:2717-29.
28. DeMali KA, Jue AL, Burridge K. IpaA targets beta1 integrins and rho to promote actin cytoskeleton rearrangements necessary for Shigella entry. J Biol Chem 2006;281:39534-41. (Pubitemid 46041913)
29. Hamiaux C, van Eerde A, Parsot C, Broos J, Dijkstra BW. Structural mimicry for vinculin activation by IpaA, a virulence factor of Shigella flexneri. EMBO Rep 2006;7:794-9. (Pubitemid 44275397)
30. Izard T, Tran Van Nhieu G, Bois PR. Shigella applies molecular mimicry to subvert vinculin and invade host cells. J Cell Biol 2006;175:465-75.
31. DeMali KA, Barlow CA, Burridge K. Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion. J Cell Biol 2002;159:881-91. (Pubitemid 36008369)
32. Venkatesan MM, Buysse JM, Kopecko DJ. Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneri. Proc Natl Acad Sci U S A 1988;85:9317-21.
33. Katz BZ, Krylov D, Aota S, Olive M, Vinson C, Yamada KM. Green fluorescent protein labeling of cytoskeletal structures-novel targeting approach based on leucine zippers. Biotechniques 1998;25:298-302, 304.
34. Peng X, Cuff LE, Lawton CD, DeMali KA. Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin. J Cell Sci 2010;123:567-77.
35. Ruoslahti E, Hayman EG, Pierschbacher M, Engvall E. Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol 1982;82:803-31.
36. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999;71:435-78. (Pubitemid 29156312)
37. Horber DH, Cattaneo-Pangrazzi RM, von Ballmoos P, Schott H, Ludwig PS, Eriksson S, et al. Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-Darabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(50′- >50′)-N4-octadecyl-1-beta-Darabinofuranosylcytosi ne. J Cancer Res Clin Oncol 2000;126:311-9. (Pubitemid 30349568)
38. Maddugoda MP, Crampton MS, Shewan AM, Yap AS. Myosin VI and vinculin cooperate during the morphogenesis of cadherin cell cell contacts in mammalian epithelial cells. J Cell Biol 2007;178:529-40. (Pubitemid 47196159)
39. Nhieu GT, Izard T. Vinculin binding in its closed conformation by a helix addition mechanism. EMBO J 2007;26:4588-96. (Pubitemid 350036624)
40. Bakolitsa C, Cohen DM, Bankston LA, Bobkov AA, Cadwell GW, Jennings L, et al. Structural basis for vinculin activation at sites of cell adhesion. Nature 2004;430:583-6. (Pubitemid 38998634)
41. Mor A, Dustin ML, Philips MR. Small GTPases and LFA-1 reciprocally modulate adhesion and signaling. Immunol Rev 2007;218:114-25. (Pubitemid 47052308)
42. Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 2009;27:339-62.
43. Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol 2005;17:509-16. (Pubitemid 41267165)
44. Ch'ng S, Tan ST. Genetics, cellular biology and tumor microenvironment of melanoma. Front Biosci 2009;14:918-28.
45. Swenson S, Ramu S, Markland FS. Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr Pharm Des 2007;13:2860-71. (Pubitemid 351545889)
46. Tucker GC. Integrins: molecular targets in cancer therapy. Curr Oncol Rep 2006;8:96-103.